Purchase Order 75D30120P09520
Award Date 9/30/20
Potential Completion Date 9/29/21
Potential Value $200K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $110,458.00 firm fixed price purchase order is for ADI Leptospirosis work, with a performance period ending August 18, 2020. Antigen Discovery is a biotechnology company that provides microarray products and services to support the CDC's disease detection and response efforts, including...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Immport Therapeutics Inc., doing business as Antigen Discovery Inc., for $30,000.00. The contract is for the provision of microarray products and services to support detection and response efforts related to pathogens such as monkeypox virus, Brucella, SARS-CoV-2, and Leptospirosis. Immport Therapeutics is a biotechnology company specializing in high throughput...
- This is a $300,000.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for SBIR 133 - ANTIGEN and has an ultimate completion date of September 9, 2025. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and related services to support infectious disease detection, monitoring, and research....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract, valued at $15,000.00, is for the provision of falciparum custom protein microarrays. Immport Therapeutics is a biotechnology company that specializes in high-throughput protein microarray technology and related services, and has...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Abclonal Science, Inc. (doing business as Abclonal Technology), a foreign-owned, self-certified small disadvantaged business. The $246,880.00 firm-fixed-price purchase order is for gene synthesis antibodies, with a completion date of August 30, 2020. The contract does not have a set-aside designation. Based on the agency and description, this contract...
- This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
- This $1,000,000 firm-fixed-price SBIR Phase II contract was awarded by the Centers for Disease Control and Prevention (CDC) to Antagen Biosciences Inc., a minority-owned, small disadvantaged business. The contract is for research and development of an engineered HIV envelope glycoprotein and novel vaccine adjuvants to enhance the efficacy of vaccines against infectious and immune-mediated diseases. This award is part of Antagen's broader portfolio of SBIR contracts, including prior awards from...
- The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract worth $87,600 to Federon Procurement Solutions, a minority-owned, self-certified small disadvantaged business in Alexandria, Virginia. The contract is for the bulk production of oligonucleotides and synthetic genes to support the development of Candidate Vaccine Viruses (CVVs) at the CDC Influenza Division. This requirement was originally posted as an $87,600 Request for Quotations (RFQ)...
- The Centers for Disease Control and Prevention awarded a $70.5K delivery order to Luminex Corp on April 27, 2018, for a Salmonella serotyping assay complete kit, with final delivery required by May 19, 2021. This firm fixed-price contract represents a standalone delivery order without set-aside designation, procured through the civilian Office of Administrative Services Procurement Management Branch. The work will be performed in Athens, Georgia, and the assay kits support CDC's public health...
- XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...